Cheviot Value Management, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1427147
BEVERLY HILLS, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$93,112
-$8,906 QoQ
Shares Held
737
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,002
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cheviot Value Management, LLC holds $85,375,796 across 9 Drug Manufacturers - General names. GILD ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
154,695 | $39,287,889 | |
| 2 | MRK |
Merck & Co., Inc.
|
171,084 | $21,984,294 | |
| 3 | PFE |
Pfizer Inc
|
612,610 | $14,751,648 | |
| 4 | ABBV |
AbbVie Inc.
|
27,894 | $7,019,246 | |
| 5 | AMGN |
Amgen Inc
|
3,892 | $1,409,371 | |
| 6 | LLY |
ELI LILLY & Co
|
581 | $696,868 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,125 | $122,442 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
737 | $93,112 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,112 | 737 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $102,018 | 732 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $89,354 | 728 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $80,253 | 723 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $79,604 | 718 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $85,494 | 763 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||